{
    "Trade/Device Name(s)": [
        "D\u00b3 Duet DFA RSV/Respiratory Virus Screening Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K081928",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061101"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LKT",
        "GNW"
    ],
    "Summary Letter Date": "December 23, 2008",
    "Summary Letter Received Date": "November 28, 2008",
    "Submission Date": "November 26, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3480"
    ],
    "Regulation Name(s)": [
        "Respiratory syncytial virus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Respiratory syncytial virus",
        "Influenza A virus",
        "Influenza B virus",
        "Adenovirus",
        "Parainfluenza virus type 1",
        "Parainfluenza virus type 2",
        "Parainfluenza virus type 3"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Aspirate",
        "Cell culture"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence assay",
        "Monoclonal antibody labeling (R-phycoerythrin, FITC)"
    ],
    "Methodologies": [
        "Direct fluorescent antibody staining"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control Slide",
        "Wash solution",
        "Mounting fluid"
    ],
    "Document Summary": "FDA 510(k) summary for D\u00b3 Duet DFA RSV/Respiratory Virus Screening Kit, an immunofluorescence-based kit for detecting RSV and screening for multiple respiratory viruses using labeled monoclonal antibodies.",
    "Indications for Use Summary": "Intended for qualitative detection and identification of respiratory syncytial virus and screening for influenza A, influenza B, adenovirus, and parainfluenza virus types 1, 2, and 3 antigens in nasal/nasopharyngeal swabs, aspirates, or cell culture from patients with signs of respiratory infection.",
    "fda_folder": "Microbiology"
}